Trial Profile
Phase II Study of ME3738 in Chronic Hepatitis C Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs ME 3738 (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- Sponsors Meiji Seika Pharma
- 06 Jun 2016 New trial record